Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC-Squawk Box Trading -- Ignore unavailable to you. Want to Upgrade?

To: NASDBULL who wrote (2424)	10/25/1999 1:55:00 PM
From: mammoth	Read Replies (1) \| Respond to of 2782

That is at least 20/40. Also, 40% actually had visual acuity improve over time (post-operative). Additionally, the range of patients able to undergo STAA's procedure it much wider, they can treat patients who do not fit within the parameters of laser surgery guidelines. Like I said, we'll see. But I doubt they would do a feature on LASIK which has already been much talked about in the news. STAA is very new and unknown to the general public.

To: NASDBULL who wrote (2424)	10/25/1999 3:17:00 PM
From: mammoth	Read Replies (2) \| Respond to of 2782

I found a link that has a pretty good summary of new technologies in eye surgery. ascrs.org Keep in mind that this article was published in 1997, so what was new then may not be new now. However, they do mention a process developed by Autonomous Tech that gave over 90% of patients 20/20 vision or better. It turns out that Autonomous Tech was recently bought out by BEAM. So Nasdbull, you may end up being right about BEAM yet. Incidentally, the procedure in BEAM's most recent PR (apex plus) is not the one that may be featured on NBC. The likely procedure is Ladarvision plus CustomCornea, which is somewhat explained in BEAMS 10/18 release. Anyways, since you may indeed be right about the company, I thought you would like to know this info in case you didn't already have it.